Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies

According to the latest GLOBOCAN data, thyroid cancer accounts for 3% of new cancer diagnoses, being the ninth most frequent cancer worldwide. However, it comprises only 0.4% of all cancer deaths, mainly due to its excellent prognosis [1].

Source: Cancer Treatment Reviews - February 28, 2022 Category: Cancer & Oncology Authors: Mar ía San Román-Gil, Javier Pozas, Diana Rosero-Rodríguez, Jesús Chamorro-Pérez, Álvaro Ruiz-Granados, Ignacio Ruz Caracuel, Enrique Grande, Javier Molina-Cerrillo, Teresa Alonso-Gordoa Source Type: research